tranexamic acid has been researched along with Experimental Hepatoma in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Excerpt | Relevance | Reference |
---|---|---|
"The fibrinolytic inhibitor tranexamic acid affects certain experimental tumours; it prolongs survival (Lewis lung adenocarcinoma), decreases tumour weight (C3H breast carcinoma), and inhibits ascitic production (AH 130 rat hepatoma)." | 3.66 | Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis. ( Astedt, B; Tropé, C, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dutta, S | 1 |
Park, JA | 1 |
Jung, JC | 1 |
Chang, Y | 1 |
Kim, TJ | 1 |
Astedt, B | 1 |
Tropé, C | 1 |
2 other studies available for tranexamic acid and Experimental Hepatoma
Article | Year |
---|---|
Gd-complexes of DTPA-bis(amide) conjugates of tranexamic acid and its esters with high relaxivity and stability for magnetic resonance imaging.
Topics: Amides; Animals; Cell Line; Cell Survival; Chick Embryo; Contrast Media; Cornea; Drug Stability; Est | 2008 |
Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis.
Topics: Adenocarcinoma; Animals; Cyclohexanecarboxylic Acids; DNA, Neoplasm; Liver Neoplasms, Experimental; | 1980 |